Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Advances in Therapy|October 21, 2025
Cost-Consequences of Adding Gliclazide Modified Release to Metformin in Patients with Uncontrolled Type 2 Diabetes in the United Arab EmiratesMohamed Farghaly, Olivier Cristeau, Fatheya Al Awadi, et al.Scientific Reports|May 3, 2018
High prevalence of diabetes among migrants in the United Arab Emirates using a cross-sectional surveyNabil Sulaiman, Salah Albadawi, Salah Abusnana, et al.Brain Sciences|December 30, 2020
Differential Expression of Inflammatory Markers in Hypoglycemia Unawareness Associated with Type 1 Diabetes: A Case ReportYousef Al Zoubi, Bashair M Mussa, Ankita Srivastava, et al.Diabetes Research and Clinical Practice|November 27, 2022
Switching to a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) is associated with improved glycaemic control in a real-world population with type 2 diabetes mellitus in the United Arab Emirates: Results from the multicentre, prospective INTENSIFY studySalah Abusnana, Fatheya Al Awadi, Hazem Aly, et al.Journal of General Internal Medicine|January 22, 2025
Noninvasive Assessment of the Severity of Liver Fibrosis in MASLD Patients with Long-Standing Type 2 DiabetesFarooq Khan, Stafny Dsouza, Amar Hassan Khamis, et al.Scientific Reports|September 29, 2022
Identification of novel differentially expressed genes in type 1 diabetes mellitus complications using transcriptomic profiling of UAE patients: a multicenter studyBashair M Mussa, Thenmozhi Venkatachalam, Ankita Srivastava, et al.European Journal of Medical Research|October 11, 2025
Saliva as a potential and non-invasive approach to identify upregulated genes associated with comorbidities of T1DM: a brief reportBashair M Mussa, Ankita Srivastava, Reeja Rajan, et al.Diabetes & Metabolic Syndrome|April 17, 2025
Prevalence of cardiovascular risk and atherosclerotic cardiovascular disease in people with type 2 diabetes in the United Arab Emirates: Results from the prevalence of atherosclerotic cardiovascular disease in patients with type 2 diabetes across Middle East and African countries (PACT-MEA) studyFatheya Al Awadi, Fauzia Rashid, Ghada Awada, et al.Diabetes Research and Clinical Practice|April 25, 2020
A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADANMohamed Hassanein, Saud Al Sifri, Shehla Shaikh, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 23, 2024
Modern-Day Management of the Dysglycemic Continuum: An Expert Viewpoint from the Arabian GulfThamer Alessa, Fatheya Al Awadi, Juma Al Kaabi, et al.Pageof 2